Liver Expert Witnesses

This highly qualified board certified expert has been in clinical practice for more than 20 years. Residency ad fellowship training were completed at Loma Linda University Medical Center and the University of Pittsburgh School of Medicine, respectively. He is actively involved in research and education: the expert serves on countless medical and surgical committees dedicated to the improvement of health care outcomes and physician education, is a reviewer and editor for many prestigious transplant journals, and has been awarded in recognition for his contributions to the specialty. The expert has authored over 250 original peer reviewed articles and abstracts and has lectured at over 150 conferences and symposia. Currently, he is the Chief of Clinical Transplantation, the Chief of Pediatric Kidney Transplantation and a Professor of Surgery at a highly ranked university affiliated medical center.

This highly qualified expert has nearly 30 years of experience in hepatology. She received her BA in biology from Columbia University before earning her MD from Mount Sinai School of Medicine. She completed an internship and residency in internal medicine at Beth Israel Medical Center before completing two fellowships: one in hepatology at Mount Sinai Medical Center and one in gastroenterology at State University Hospital at Stony Brook. This expert is board-certified in internal medicine with a subspecialty in gastroenterology. She is active in her field as a member of both the International and American Association for the Study of Liver Disease, as well as the American Gastroenterological Association. She is highly involved in hepatology research and is a leading researcher in the realm of liver disease, having authored numerous publications on the topic. She has formerly served as the director of hepatology and clinical professor of medicine at NYU Langone Medical Center, global head of hepatology for Kadmon Pharmaceuticals, and global development lead of nonalcoholic steatohepatitis for Shire Pharmaceuticals. Currently, this expert serves as the CEO of a liver disease consulting company, as well as the head of liver disease development clinical sciences for a pharmaceutical company based in New York.

This board certified Gastroeneterology and Hepatology expert completed fellowship training in Gastroenterology and Advanced Hepatology. He is involved in clinical and translational research and has a record of publication, presentation, and funded research. He has authored and co-authored a number of articles in peer-reviewed journals. This expert specializes in general and transplant Hepatology. He currently serves as Medical Director of the Liver Transplant Program at a major university hospital.

This expert's is a Physician-Scientist (M.D. and Ph.D) who serves as an attending hepatologist at a top tier university. He specializes the care of viral hepatitis (HCV and HBV) and other liver diseases. His research interests have been centered on hepatitis C virus (HCV) virology, pathogenesis, and virus-host interaction including immune response. For the past 10 years during his PhD and Post-Doctoral training, he has investigated viral-host interactions that regulate HCV viral replication through the activation of intracellular innate immune response. In recent years, he has focused on understanding how host cell innate immune pathways sense HCV infection and initiate the host response which involves type I interferon and proinflammatory cytokine production to regulate hepatic immunity. After a recent transition to an independent faculty position, his laboratory continues to investigate virus-host interactions that regulates disease outcome and pathogenesis of HCV infection. He has extensive expertise and skills in virology, cell signaling, cytokine biology, and cell biology. His role as a physician specializing in the care of viral hepatitis at an academic medical center offers the unique integration of basic science and clinical/translational science into the laboratory research program.